Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Sarepta Therapeutics, Inc. has filed 1,527 SEC EDGAR filings since 28 Jan 1997

SEC filing history

Showing 876-900 of 1,000 matching filings.

Per page
25
Current page
36
CT ORDER File 001-14895

CT ORDER filing

Filing date
16 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2012
Reporting date
14 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-184807

FORM S-3ASR

Filing date
07 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
07 Nov 2012
Reporting date
07 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
06 Nov 2012
Reporting date
05 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
04 Oct 2012
Reporting date
03 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-14895

FORM 8-K AMENDMENT NO. 1

Filing date
04 Oct 2012
Reporting date
02 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
03 Oct 2012
Reporting date
02 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
27 Sep 2012
Reporting date
27 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
19 Sep 2012
Reporting date
18 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-180258

PRELIMINARY PROSPECTUS SUPPLEMENT NO. 2 TO PROSPECTUS DATED MARCH 12, 2012

Filing date
19 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Sep 2012
Reporting date
07 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Sep 2012
Reporting date
07 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
04 Sep 2012
Reporting date
04 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-180258

PROSPECTUS SUPPLEMENT

Filing date
04 Sep 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

FORM 8-K

Filing date
04 Sep 2012
Reporting date
29 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-14895

CURRENT REPORT ON FORM 8-K

Filing date
29 Aug 2012
Reporting date
23 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Aug 2012
Reporting date
23 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Aug 2012
Reporting date
23 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Aug 2012
Reporting date
23 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .